Quantum Biopharma (QNTM) Stock Price, News & Analysis

Company Overview

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $7.60 to $8.35
• 50-Day Range: $2.91 to $14.50
• 52-Week Range: $2.70 to $18.00
• Volume: 201,178 shs
• Average Volume: 1.20 million shs
• Market Capitalization: $15.43 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

QNTM Stock Analysis - Frequently Asked Questions

How have QNTM shares performed this year?

Quantum Biopharma's stock was trading at $3.68 at the beginning of 2025. Since then, QNTM shares have increased by 116.0% and is now trading at $7.95.
View the best growth stocks for 2025 here.

How were Quantum Biopharma's earnings last quarter?

Quantum Biopharma Ltd. (NASDAQ:QNTM) announced its earnings results on Friday, March, 28th. The company reported ($2.89) earnings per share for the quarter, missing analysts' consensus estimates of ($0.80) by $2.09.

How do I buy shares of Quantum Biopharma?

Shares of QNTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Quantum Biopharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Quantum Biopharma investors own include Jiuzi (JZXN), Aethlon Medical (AEMD), Aditxt (ADTX), Adial Pharmaceuticals (ADIL), Avalon GloboCare (ALBT), Ainos (AIMD) and AMC Entertainment (AMC).

Company Calendar

• Last Earnings: 3/28/2025
• Today: 4/02/2025
• Next Earnings (Estimated): 5/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:QNTM
• Previous Symbol: NASDAQ:QNTM
• CIK: 1771885
• Web: www.fsdpharma.com
• Phone: 416-854-8884
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($15.70)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-17,900,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -84.21%
• Return on Assets: -62.63%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.76
• Quick Ratio: 3.76

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $21.29 per share
• Price / Book: 0.38

Miscellaneous

• Outstanding Shares: 1,919,000
• Free Float: 1,755,000
• Market Cap: $15.46 million
• Optionable: N/A
• Beta: 0.37